300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Cameroon
Oman
Colombia
New Zealand
Australia
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Seychelles
Moldova
United Kingdom
Botswana
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
Canada
India
Germany
Ireland
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Hong Kong (July 2026)

The most active venture capital funds and angel investors investing in Hong Kong Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Hong Kong Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Alibaba Entrepreneurs Fund
VC Fund
4 Hong Kong, Taiwan, United States Series A, Seed, Series B Software, E-Commerce, Artificial Intelligence $1.2M–$150M
Lever VC
VC Fund
3 United States, China, United Kingdom Seed, Series A, Pre-Seed Food and Beverage, Biotechnology, Food Processing $500k–$18M
Loyal VC
VC Fund
3 United States, Canada, United Kingdom Pre-Seed, Seed Artificial Intelligence, Software, FinTech $30k–$2.5M
Bold Capital Partners
VC Fund
2 United States, Hong Kong, India Series A, Series B, Seed Health Care, Biotechnology, Software $2M–$58M
Gobi Partners GBA
VC Fund
2 China, Hong Kong Seed, Series A, Angel Biotechnology, Medical, Solar $1.4M–$13M
PT Medion
VC Fund
2 Hong Kong Seed, Venture - Series Unknown Medical, Agriculture, Biotechnology
FHB Ventures
VC Fund
2 Hong Kong, United States Seed, Series A, Series B Medical, Agriculture, Biotechnology
Whist Subholdings
VC Fund
2 Hong Kong Seed Medical, Agriculture, Biotechnology
Simmons Foods
VC Fund
2 Hong Kong Seed, Venture - Series Unknown Medical, Agriculture, Biotechnology
CPT Capital
VC Fund
2 United States, Israel, United Kingdom Seed, Series A, Series B Food and Beverage, Biotechnology, Food Processing $1.3M–$226M
Artesian VC
VC Fund
2 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Health Care $40k–$15M
Arkansas Development Finance Authority
VC Fund
2 United States, Hong Kong Seed, Pre-Seed Medical, Biotechnology, Manufacturing
Innovation and Technology Venture Fund
VC Fund
2 Hong Kong, China, Singapore Series A, Seed, Series B Information Technology, Software, Artificial Intelligence $250k–$150M
Formic Ventures
VC Fund
1 United States, United Kingdom, Hong Kong Seed, Series A Biotechnology, Health Care, Biopharma $1.3M–$61M
WuXi AppTec
VC Fund
1 United States, China, Israel Series A, Series B, Series C Biotechnology, Pharmaceutical, Health Care $6M–$130M
StartUp Health
VC Fund
1 United States, Canada, United Kingdom Seed, Pre-Seed Health Care, Wellness, Medical $20k–$4M
Particle Accelerator Limited (ParticleX)
VC Fund
1 Hong Kong, United States, Singapore Seed, Pre-Seed, Series A Artificial Intelligence, Information Technology, Software $1M–$6.9M
Alon Capital Ltd
VC Fund
1 Hong Kong Series A Biopharma, Life Science, Biotechnology
Beyond Ventures
VC Fund
1 China, Hong Kong, Canada Seed, Series A Information Technology, Artificial Intelligence, Health Care $720k–$138M
Longevity Vision Fund
VC Fund
1 United States, Hong Kong, Isle of Man Series B, Series C, Series A Biotechnology, Health Care, Medical $37M–$300M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
S2G Investments
VC Fund
1 United States, Canada, Israel Series A, Series B Food and Beverage, Agriculture, Biotechnology $4M–$100M
Good Startup
VC Fund
1 United States, Canada, Israel Seed, Series A, Pre-Seed Food and Beverage, Biotechnology, Food Processing $1.2M–$13M
Proxima Ventures Ltd
VC Fund
1 China, United States, Israel Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $213k–$150M
Hillhouse Investment
VC Fund
1 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$220M
ASBV
VC Fund
1 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology
FutureX Capital
VC Fund
1 China, United States, Hong Kong Seed, Series B, Series A Artificial Intelligence, Software, Health Care
Hillhouse Ventures
VC Fund
1 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care
Apis Partners
VC Fund
1 India, South Africa, Hong Kong Private Equity, Series B Financial Services, Payments, FinTech
LongeVC
VC Fund
1 United States, United Kingdom, Canada Seed, Series A Health Care, Biotechnology, Therapeutics $1.5M–$94M
Thia Ventures
VC Fund
1 United States, France, Denmark Series A, Seed, Series B Biotechnology, Health Care, Food and Beverage $3.3M–$53M
Human Longevity and Performance Impact Venture Fund
VC Fund
1 Hong Kong Series A Health Care, Biotechnology
Jim Mellon
Angel
1 United States, United Kingdom, Israel Series A, Seed Biotechnology, Food and Beverage, Health Care $536k–$46M
Venturra
VC Fund
1 Indonesia, Singapore, Vietnam Seed, Series A, Series B E-Commerce, Financial Services, Software $1M–$60M
Vectr
VC Fund
1 United States, Hong Kong, Singapore Seed, Series A, Series B FinTech, Financial Services, Artificial Intelligence $547k–$70M
AEF Greater Bay Area Fund
VC Fund
1 Hong Kong, China, Macao Series A, Seed, Series B Artificial Intelligence, Life Science, Biotechnology $2.5M–$28M
Pavilion Capital
VC Fund
1 United States, Japan, Singapore Series B, Series A, Series C Biotechnology, Health Care, Information Technology $2M–$425M
ETP Ventures
VC Fund
1 China, Hong Kong Seed, Angel, Series A Health Care, Biotechnology, Medical
Markus Haefeli
Angel
1 Hong Kong Seed Biotechnology
The International Medical
VC Fund
1 Hong Kong Seed Medical, Hospitality, Biotechnology
208 Seed Ventures
VC Fund
1 Hong Kong Seed Biotechnology
WI Harper Group
VC Fund
1 United States, Taiwan, China Series A, Seed, Series B Software, Health Care, Biotechnology $1.4M–$41M
Joel Neoh
Angel
1 Malaysia, Hong Kong, Singapore Seed, Angel, Pre-Seed E-Commerce, Apps, Mobile
Juvenescence
VC Fund
1 United States, Hong Kong, Isle of Man Series A, Seed Biotechnology, Pharmaceutical, Health Care $3M–$19M
AngelHub
VC Fund
1 Hong Kong, United States, Israel Seed, Series A, Pre-Seed Software, FinTech, Blockchain $500k–$4.8M
Capital Union Investments
VC Fund
1 Hong Kong, United States Seed, Series A SaaS, Genetics, Software $2M–$10M
Ping An
VC Fund
1 China, United States, Japan Series A, Series E Health Care, FinTech, Finance $1.4M–$300M
Coent Venture Partners
VC Fund
1 Taiwan, China, Hong Kong Seed, Series A Apps, SaaS, Travel $275k–$800k
Merrill Lynch
VC Fund
1 United States, India, United Kingdom Series B, Series C Software, Information Technology, Internet $10M–$85M
Gobi Partners
VC Fund
1 China, Malaysia, Hong Kong Series A, Seed, Series B E-Commerce, Financial Services, Internet $709k–$37M
Access all 135 investors in Hong Kong Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Alibaba Entrepreneurs Fund
VC Fund · Causeway Bay, Hong Kong Island, Hong Kong · 4 investments in Hong Kong Biotech startups

The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, Taiwan, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $1.2M–$8M; Series A $2M–$68M; Series B $7M–$150M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
  • Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
  • Rice Robotics Limited — The friendliest robot at your service.
Show all investments...

Lever VC
VC Fund · New York, New York, United States · 3 investments in Hong Kong Biotech startups

Lever VC is a U.S.-Hong Kong venture capital fund founded by Managing Partner Nick Cooney and investing in early stage companies in the alternative protein sector (plant-based and “clean”/cell-based meat, egg and dairy companies). Lever VC operates globally, with offices in Hong Kong and the U.S. and staff in the US, Hong Kong, Europe, andIsrael. Entrepreneurs and startups interested in connecting with Lever VC about possible investment can reach the team and submit information about their company at http://www.levervc.com.Managing Partner Nick Cooney is the Co-Founder and former Managing Trustee of New Crop Capital, a private venture capital trust vehicle investing in the alternative protein space, and is Co-Founder of the Good Food Institute, the world’s largest non-governmental organization working to grow the alternative protein space. The General Partners at Lever VC have deployed over $1.5 billion in capital over the past decade across a variety of sectors, including over thirty deals in the alternative protein space.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $700k–$8.1M; Pre-Seed $500k–$850k; Series A $3.5M–$18M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Omni — Omni provides Healthy Vegan Dog Food in the UK, made by vets to be a nutritionally complete meal for your dog. Feed your dog all the goodness of plants backed by science.
  • Incapto Coffee — Incapto Coffee offers the sale of the automatic coffee machine and a subscription system for coffee beans.
  • ns/tx industries — ns/tx industries is a food manufacturing and technology company that processes and sells fish and meat products.
Show all investments...

Loyal VC
VC Fund · Toronto, Ontario, Canada · 3 investments in Hong Kong Biotech startups

Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, FinTech
  • Stage:Pre-Seed, Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 153
  • Round size: Seed $100k–$2.5M; Pre-Seed $30k–$1M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Peerby Classic — Borrow and rent goods from others nearby - affordable, convenient and green. Tools, bikes, party equipment, electronics and more. Try it now.
  • Zobi — Zobi’s not just Artificial Intelligence, it’s Home Intelligence. Our smart, brand-agnostic solutions take a holistic view of homes - people, devices, networks, habits. They build an anonymous profile for each home, then use that intel to spot unusual behaviour and stop cybercriminals.
  • Finverity — Finverity provides technology, working capital and expertise to give banks, NBFIs, financiers and companies a strategic advantage in supply chain finance
Show all investments...

Bold Capital Partners
VC Fund · Santa Monica, California, United States · 2 investments in Hong Kong Biotech startups, 7 in the past 12 months

A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, Hong Kong, India

Investor stats

  • Total investments: 129
  • Round size: Seed $2M–$15M; Series A $6M–$37M; Series B $15M–$58M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Evergreen — Omeat is real, lip-smacking meat, grown from cells, outside the animal. No sacrifice required.
  • KeyCare — KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.
  • MagicCube — MagicCube is the Software Defined Trust (SDT) category with its software TEE-based platform. The technology enables large-scale deployment and management of IoT and mobile- secure solutions to consumers.
Show all investments...

Gobi Partners GBA
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 2 investments in Hong Kong Biotech startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Solar
  • Stage:Seed, Series A, Angel
  • Geography: China, Hong Kong

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$13M; Series A $1.4M–$12M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • GenEditBio — GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.
  • Immuno Cure — Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders.
  • Luquos Energy — Luquos Energy is a renewable energy company that offers energy consulting and management services.
Show all investments...

PT Medion
VC Fund · 2 investments in Hong Kong Biotech startups

PT Medion is a venture capital investment firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed, Venture - Series Unknown
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

FHB Ventures
VC Fund · 2 investments in Hong Kong Biotech startups

FHB Ventures is a venture capital firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Hong Kong, United States

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Whist Subholdings
VC Fund · 2 investments in Hong Kong Biotech startups

Whist Subholdings is a venture capital investment firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Simmons Foods
VC Fund · Siloam Springs, Arkansas, United States · 2 investments in Hong Kong Biotech startups

Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Biotechnology
  • Stage:Seed, Venture - Series Unknown
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 2 investments in Hong Kong Biotech startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 59
  • Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Xias Bio — Xias Bio is a biotechnology startup specializing in the production of recombinant proteins, offering formulators advanced soluble, active ingredients with improved attributes such as enhanced gel and film formation, as well as antioxidant properties. The company creates non-immunogenic natural motifs to produce a better delivery platform offunctionalities for research, beauty, and healthcare.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Artesian VC
VC Fund · Melbourne, Victoria, Australia · 2 investments in Hong Kong Biotech startups

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 246
  • Round size: Seed $135k–$4.6M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Vaulta — Discover Vaulta's high-performance batteries for sustainable energy solutions. Revolutionising power with easy installation, maintenance, and recycling. Join the Australian-made energy revolution today!
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
  • Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Show all investments...

Arkansas Development Finance Authority
VC Fund · Little Rock, Arkansas, United States · 2 investments in Hong Kong Biotech startups

Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: United States, Hong Kong

Investor stats

  • Total investments: 6
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
  • BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
  • United States Steel — U. S. Steel Home Page
Show all investments...

Innovation and Technology Venture Fund
VC Fund · 2 investments in Hong Kong Biotech startups

The HK$2 billion ITVF was set up by the Hong Kong Government with a view to creating a vibrant local innovation and technology eco-systems

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, China, Singapore

Investor stats

  • Total investments: 33
  • Round size: Seed $250k–$90M; Series A $375k–$14M; Series B $1M–$150M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Varadise — Varadise is a digital twin platform offering technology services, cloud platforms, and business services comprising IoT and AI.
  • LeapXpert — LeapXpert delivers business communication governance and compliance with a platform that ensures secure, compliant messaging across multiple channels.
  • Cornerstone Robotics — Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Biopharma
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 39
  • Round size: Seed $1.3M–$12M; Series A $17M–$61M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Show all investments...

WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Biotech startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 45
  • Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2015

Portfolio highlights

  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 195
  • Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
  • Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

Particle Accelerator Limited (ParticleX)
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Hong Kong, United States, Singapore

Investor stats

  • Total investments: 23
  • Round size: Seed $1.1M–$5.5M; Series A $1M–$6.9M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Finquest — Tap into the largest private company database in the world to change the way you find and connect with M&A targets using Data, AI, & People.
  • MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
  • Ephod Technology — Ephod Intelligence is fund managers' research copilot, offering investment hypothesis validation, and personalized trading signals to empower fundamental research.
Show all investments...

Alon Capital Ltd
VC Fund · Rosh Ha'ayin, HaMerkaz, Israel · 1 investments in Hong Kong Biotech startups

Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

Beyond Ventures
VC Fund · Tsuen Wan, New Territories, Hong Kong · 1 investments in Hong Kong Biotech startups

A US$60M startup fund aiming at revitalizing HK’s ecosystem of innovation by connecting local venture capitalists and entrepreneurs to invest in ideas and startups. It is co-founded by Hony Capital, eGarden Ventures & several successful HK entrepreneur

Show more...

Investment focus

  • Industry: Information Technology, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: China, Hong Kong, Canada

Investor stats

  • Total investments: 24
  • Round size: Seed $720k–$3M; Series A $1.6M–$138M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Chaomu Technology — Chaomu Technology is a high-tech research and development enterprise dedicated to solving difficult human eye diseases. The company provides medical intelligent high-tech equipment and solutions. The pursuit of super purpose is to alleviate the increasing sub-light suffering of eye disease patients worldwide in a more scientific manner and torealize the dream of returning hundreds of millions of eye disease patients to a bright world.
  • YAS — Every Moment Matters!YAS MicroInsurance is a Hong Kong-based next-generation InsurTech company to reshape the industry with simple, affordable, flexible MicroInsurance products tailored to customer’s needs.Built on innovative technology, YAS provides on-demand MicroInsurance products that activate protection for you anywhere and anytime on theYAS app. Whether it is your daily ride to work, a hike in the mountains, or a trip to the vet with your furbaby, we care about each moment in your life. YAS Microinsurance is redefining insurance. Simple, affordable, efficient, and coverage you control at your fingertips anytime, anywhere.
  • GOGO Digital Innovation — GOGO Digital Innovation is a trendy digital asset art collection platform.
Show all investments...

Longevity Vision Fund
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of agingLongevity Vision Fund provides Seedto Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, Hong Kong, Isle of Man

Investor stats

  • Total investments: 21
  • Round size: Series B $37M–$230M; Series C $65M–$300M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Biolinq — Introducing a revolutionary platform for metabolic health.
  • Senda Biosciences — We work at the frontier of programmable medicines. We power our bioplatform and product candidates by harnessing evolution and AI. We operate with purpose and urgency on behalf of people everywhere. We aim to generate life-changing impact for the world.
  • Tessera Therapeutics — Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine,building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Biotech startups, 7 in the past 12 months

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 79
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

S2G Investments
VC Fund · Chicago, Illinois, United States · 1 investments in Hong Kong Biotech startups

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 203
  • Round size: Series A $4M–$40M; Series B $5.9M–$100M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reversed engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
  • Common Energy — Save Money Each Month. Use Clean Energy.
  • Big Bold Health — Big Bold Health® is a platform company providing immune health solutions through nature's wisdom and modern science.
Show all investments...

Good Startup
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Good Startup exists to remove animals from the food system.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 18
  • Round size: Seed $1.2M–$13M; Series A $6M–$12M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $34M in 2022

Portfolio highlights

  • ns/tx industries — ns/tx industries is a food manufacturing and technology company that processes and sells fish and meat products.
  • StrainX Bioworks
  • Standing Ovation — Animal-free dairy cheese
Show all investments...

Proxima Ventures Ltd
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Hong Kong Biotech startups

Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Israel

Investor stats

  • Total investments: 20
  • Round size: Seed $750k–$4.5M; Series A $213k–$10M; Series B $10M–$150M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
  • Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 1 investments in Hong Kong Biotech startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$142M; Series B $14M–$219M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 1 investments in Hong Kong Biotech startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 27
  • Lead/follow: no public data

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

FutureX Capital
VC Fund · Central, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

FutureX Capital is an investment firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series B, Series A
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 25
  • Lead/follow: no public data

Portfolio highlights

  • Gewu Technology — Gewu Technology is an innovative IoT technology company, likely plays a role in building a future smart home by developing and integrating smart hardware and software solution
  • Lymow Technology — Lymow Technology is a manufacturer of lawn mowing robots.
  • Touchable Future — Touchable Future is an intelligent hardware company focusing on interactive innovation, committed to analyzing and customizing entertaining and emotional experiences for adults.
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 69
  • Lead/follow: no public data

Portfolio highlights

  • RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
  • HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
  • Hecheng New Materials Technology — Hecheng New Materials Technology is a manufacturing company offering bearing electrical corrosion and electrical insulation solutions.
Show all investments...

Apis Partners
VC Fund · London, England, United Kingdom · 1 investments in Hong Kong Biotech startups

Apis Partners LLP backs growth financial services innovators who create transformative impact in their communities.

Show more...

Investment focus

  • Industry: Financial Services, Payments, FinTech
  • Stage:Private Equity, Series B
  • Geography: India, South Africa, Hong Kong

Investor stats

  • Total investments: 42
  • Lead/follow: no public data

Portfolio highlights

  • KPay — KPay is a financial technology company that provides comprehensive payment collection solutions to SME merchants. It helps businesses streamline management processes and improve customer retention, business efficiency, and flexibility. KPay creates a more intuitive approach to running a business that enables merchants to reach their maximumpotential.
  • Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
  • MNT-Halan — MNT-Halan is a microfinance lending and payments company.
Show all investments...

LongeVC
VC Fund · Lugano, Ticino, Switzerland · 1 investments in Hong Kong Biotech startups

With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 20
  • Round size: Seed $1.5M–$12M; Series A $17M–$94M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Trogenix — Trogenix operates as a therapeutics company, that treats aggressive cancers.
  • Valink Therapeutics — Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
  • PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 1 investments in Hong Kong Biotech startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 20
  • Round size: Seed $3.3M–$20M; Series A $6.3M–$53M; Series B $24M–$50M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Show all investments...

Human Longevity and Performance Impact Venture Fund
VC Fund · 1 investments in Hong Kong Biotech startups

Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergisticecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Show all investments...

Jim Mellon
Angel · 1 investments in Hong Kong Biotech startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Health Care
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 32
  • Round size: Seed $536k–$20M; Series A $4.6M–$46M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • OncoSenX — OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease.
  • Netwealth — Netwealth provides expert investment management and tailored wealth planning solutions, helping you confidently achieve your financial goals.
  • Repair Biotechnologies — Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling humanbeings to improve their health span through targeting the causes of age-related diseases and ageing itself.
Show all investments...

Venturra
VC Fund · Jakarta, Jakarta Raya, Indonesia · 1 investments in Hong Kong Biotech startups

Empowering outstanding entrepreneurs across Southeast Asia in creating the next defining technology companies.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Seed, Series A, Series B
  • Geography: Indonesia, Singapore, Vietnam

Investor stats

  • Total investments: 69
  • Round size: Seed $1M–$6M; Series A $4M–$12M; Series B $4M–$60M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $150M in 2015

Portfolio highlights

  • FR8Labs — FR8Labs offers a practical freight forwarder solution that includes all of the modules required, without the extraneous trappings of overly sophisticated features that may not use but wind up paying for.
  • Saladin — Saladin is an online platform that provides life, health, automotive, and travel insurance services.
  • Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.
Show all investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Hong Kong, Singapore

Investor stats

  • Total investments: 75
  • Round size: Seed $547k–$5.3M; Series A $1M–$37M; Series B $12M–$70M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show all investments...

AEF Greater Bay Area Fund
VC Fund · Beijing, Beijing, China · 1 investments in Hong Kong Biotech startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Life Science, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, China, Macao

Investor stats

  • Total investments: 14
  • Round size: Seed $2.5M–$5.1M; Series A $7M–$19M; Series B $14M–$28M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
  • Sandwich — Sandwich is an online platform that provides real-time trend analysis tools for developing ad campaigns and creating Meta Ads plans.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Pavilion Capital
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Provides growth equity to market leading companies in the United States and China

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, Japan, Singapore

Investor stats

  • Total investments: 75
  • Round size: Series A $2M–$90M; Series B $18M–$425M; Series C $35M–$255M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2018

Portfolio highlights

  • Rebellions — AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration.
  • Lhoopa — Making homeownership achievable for every Filipino family.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Show all investments...

ETP Ventures
VC Fund · 1 investments in Hong Kong Biotech startups

ETP Ventures

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel, Series A
  • Geography: China, Hong Kong

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • SEIMEI — SEIMEI is a nutrition and anti-aging biotechnology brand.
  • Dima Biotech — DIMA uses HEK293 mammalian cell expression system to produce many druggable proteins especially membrane proteins. This will not only ensure the authentic
  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Show all investments...

Markus Haefeli
Angel · 1 investments in Hong Kong Biotech startups

Markus Haefeli is Chairman of PTG Food and Regal Springs.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Show all investments...

The International Medical
VC Fund · Yau Tsim Mong, Kowloon, Hong Kong · 1 investments in Hong Kong Biotech startups

The International Medical is an investment firm

Show more...

Investment focus

  • Industry: Medical, Hospitality, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BioMed Technology Holdings — BioMed develops a personalized intestinal treatment plan with probiotics, a series of probiotic products for adults and children, to solve problems such as moisture sensitivity, detoxification, weight loss, emotional stress, etc., recommend the best adult and children probiotics for you, buy now!
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
208 Seed Ventures
VC Fund · Columbia, Missouri, United States · 1 investments in Hong Kong Biotech startups

208 Seed Ventures provides early-stage investments in frontier technologies. 2SV brings Midwestern leaders, investors, and operators together and invests in startups pushing current technological limits. Their network provides smart capital and resources for companies with big ideas to accelerate growth.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Show all investments...

WI Harper Group
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

We take a diversified approach, investing in the early stage, across multiple sectors with our deep domain expertise.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 151
  • Round size: Seed $1.4M–$5M; Series A $2M–$15M; Series B $6M–$41M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $174M in 2016

Portfolio highlights

  • Xsensio — Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
  • Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
  • R+W — R+W is a global agency & startup incubator based in Hong Kong, Taipei, New York and Washington DC.
Show all investments...

Joel Neoh
Angel · Kuala Lumpur, Kuala Lumpur, Malaysia · 1 investments in Hong Kong Biotech startups

Joel Neoh is the Founder and CEO of Fave. He attended Monash University.

Show more...

Investment focus

  • Industry: E-Commerce, Apps, Mobile
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Malaysia, Hong Kong, Singapore

Investor stats

  • Total investments: 9
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Evo — Social Commerce Software
  • Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
  • Snaptee — Design your personalized t-shirts with Snaptee. Get it from AppStore and Google Play. Create your t-shirt collection with Instagram photos or your favorite snapshot pictures. Snaptee realize your creativity!
Show all investments...

Juvenescence
VC Fund · Douglas, NA - Isle of Man, Isle of Man · 1 investments in Hong Kong Biotech startups

We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Seed
  • Geography: United States, Hong Kong, Isle of Man

Investor stats

  • Total investments: 14
  • Round size: Series A $3M–$19M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
  • Morphoceuticals — Reprogramming the Software of Life: Understanding the bioelectric network that controls tissue repair and organ regeneration
  • MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
Show all investments...

AngelHub
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Join the movement toward democratised private markets, where investing is open to everyone. Discover a range of vetted tech investments, embodying the spirit of innovation in Web3, FinTech, AI, and ESG. Transform your investment strategy for a smarter, more sustainable future.

Show more...

Investment focus

  • Industry: Software, FinTech, Blockchain
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Hong Kong, United States, Israel

Investor stats

  • Total investments: 24
  • Round size: Seed $1.1M–$4.8M; Pre-Seed $500k–$2.3M; Series A $3M–$4M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Pitz — PITZ is building the infrastructure layer for the $1T global auto repair industry — starting with Latin America, expanding to the US in Q4 2026. The platform combines voice-driven AI diagnostics, automated parts procurement, and embedded financing into a single system of record for independent repair shops. In 9 months: $1.78M ARR, 1,462 activeworkshops across Mexico and Brazil, 83% gross margin, 70% subscription revenue, and NRR above 100%. Founded in 2025. Delaware C-Corp. Seed stage.
  • Antiverse — Designing biologics for 100 challenging targets
  • Nufi — At Nufi we provide modular building blocks (or legos) that you can connect together to quickly create your own solutions. We take care of all of the technical and regulatory complexities so that you can focus on bringing your products to reality. We are the legos of fintech and our goal is to empower everyone to build financial products.
Show all investments...

Capital Union Investments
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach ofproviding unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.

Show more...

Investment focus

  • Industry: SaaS, Genetics, Software
  • Stage:Seed, Series A
  • Geography: Hong Kong, United States

Investor stats

  • Total investments: 3
  • Round size: Seed $2M–$10M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bringhub — Bringhub is a contextual marketing platform that enables digital media and marketers to drive product discovery and sales. We have developed the most comprehensive contextual analysis and optimization engine on the market. We call it Sweeten.
  • Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
  • Dash Living — Dash Living offers rental services and solutions for urban professionals. Dash offers panoramic all-inclusive rental options across over 1,000 units that they manage. Their mission is to create a global accommodation community through sharing economies and tech, empowering today's hyper-mobile, tech-savvy millennials to live in the expensivecities in the world.
Show all investments...

Ping An
VC Fund · Shenzhen, Guangdong, China · 1 investments in Hong Kong Biotech startups

Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.

Show more...

Investment focus

  • Industry: Health Care, FinTech, Finance
  • Stage:Series A, Series E
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 28
  • Round size: Series A $1.4M–$300M; Series E $7.1M–$200M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Lixiangjia — The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high networth families. Professional overseas asset reconfiguration plan.
  • Biren Technology — Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system.The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on generalcomputing, combining versatility and specificity.As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.
  • Hangzhou Yingde Gas — Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.
Show all investments...

Coent Venture Partners
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Coent Venture Partners provides seed and venture-stage funding to brilliant entrepreneurs and companies across all sectors in Asia. The company backed these entrepreneurs and companies with unparalleled support in funding, management, overseas business development, and exposure to their network.

Show more...

Investment focus

  • Industry: Apps, SaaS, Travel
  • Stage:Seed, Series A
  • Geography: Taiwan, China, Hong Kong

Investor stats

  • Total investments: 4
  • Round size: Seed $275k–$800k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • QLL — QLL (Quick Language Learning) Pte. Ltd. is a company specialized in developing language learning apps, they are based in Taiwan and registered in Singapore. 2007, they launched a break-through Chinese learning gadget, “Pocket Chinese Tutor”, it is an Mp4 player with Chinese speech assessment function, it can help learner correct their accent ofspeaking Chinese.
  • Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
  • HelloWings — "See" the cheapest fare, year-round and fees included. Customized combination tickets. HelloWings ensures you'll arrive to destination on budget & in style.
Show all investments...

Merrill Lynch
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Merrill Lynch Wealth Management has the financial advisors and expertise to help you achieve your goals at any stage of your life or career.

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Series B, Series C
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 90
  • Round size: Series B $10M–$80M; Series C $10M–$85M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
  • Eldorado Gold Corp. — Eldorado is a global gold mining company with a local operating philosophy.
  • Banco de Occidente, S.A. — Banco de Occidente is the fifth largest bank in Colombia by asset level and portfolio at June 30, 2016. It has national coverage and a portfolio of integrated products and services, offered through a network of 241 offices and 336 ATMs 9,671 banking correspondents and other features.
Show all investments...

Gobi Partners
VC Fund · Kuala Lumpur, Kuala Lumpur, Malaysia · 1 investments in Hong Kong Biotech startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Internet
  • Stage:Series A, Seed, Series B
  • Geography: China, Malaysia, Hong Kong

Investor stats

  • Total investments: 254
  • Round size: Seed $709k–$8M; Series A $1.5M–$20M; Series B $5.5M–$37M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $1.3B in 2023

Portfolio highlights

  • Eko — Turning workplaces into places where all employees can thrive.
  • Camera360 — Camera360 is a mobile phone camera application. Through a variety of solutions, including Camera360 Ultimate, HelloCamera, Movie360, Pink360, Camera360 Cloud, Camera360 SDK and Web Camera360, Camera360 hopes to build an ecosystem for the modern creatives to capture, compose and share the beautiful moments of their lives.
  • GoWork — GoWork is Jakarta's leading premium coworking and office space rental with the mission to provide companies with dynamic workspaces of hybrid arrangements and satellite locations.
Show all investments...

Biotech Investor funding in Hong Kong at a glance

Stats across 60 deals from 135 investors.

135
investors
in Hong Kong Biotech startups
60
deals
in Hong Kong Biotech startups
$15M
median round
in Hong Kong Biotech startups
30%
lead investors
lead at least one round
22%
Series A
most common funding stage
92/8
VC / Angel
share of investor count

Access all 135 investors in Hong Kong Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 135 investors investing in Hong Kong Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists